Last updated: August 8, 2025
Introduction
South Korean patent KR20130103826, filed on July 16, 2013, and granted on January 6, 2015, pertains to innovations in the pharmaceutical field, specifically focusing on formulations, compositions, or methods related to drugs. As a critical part of the pharmaceutical patent landscape, understanding its scope and claims provides insight into the patent protections it affords, competitors' potential infringements, and the competitive positioning within South Korea’s pharmaceutical industry.
This analysis offers an in-depth review of the patent's scope, claims, the broader patent landscape, and strategic implications for stakeholders. The review is based on the publicly available patent documents, including the patent specification, claims, and relevant prior art references, to facilitate an informed understanding of the patent's significance.
Scope and Content Overview
KR20130103826 primarily covers a novel pharmaceutical composition with specific active ingredients, formulation methods, and intended therapeutic uses. The patent’s scope is defined mainly through its claims, which delineate the boundaries of patent protection. The invention's core aspects involve:
- A unique chemical compound or a mixture thereof with enhanced efficacy or stability.
- A method of manufacturing the composition.
- Therapeutic applications, possibly targeting a specific disease or condition.
- Specific dosage forms or delivery mechanisms designed for optimal bioavailability.
Although detailed chemical structures and formulations are confidential, the primary focus remains on protecting inventive aspects that improve upon prior art, either through chemical modifications or novel processing techniques.
Claims Analysis
The claims of KR20130103826 set the scope of patent protection and are critical in determining what infringements may occur and what is considered patentable over prior art. A typical structure of patent claims includes:
-
Independent Claims: These articulate the broadest scope. For this patent, an independent claim likely addresses a pharmaceutical composition comprising specific active molecules, or a method for producing or administering the composition.
-
Dependent Claims: These narrow the scope by adding specific features such as concentration ranges, particular carriers, excipients, or specific delivery systems.
Key Elements of the Claims:
-
Active Ingredient(s): The core pharmacologically active compound(s), possibly with chemical modifications to improve potency or stability.
-
Formulation Features: Details about excipients, stabilizers, or delivery mechanisms that enhance drug performance.
-
Method of Use: Therapeutic methods, including indications, dosing regimens, or specific patient populations.
-
Manufacturing Process: Steps or conditions specific to preparing the composition to attain desirable characteristics.
Claim Strategies and Implications:
- The broad independent claims aim to cover a wide spectrum of similar compounds or formulations.
- Narrow dependent claims protect specific embodiments, enabling effective patent enforcement.
- The combination of claims indicates a comprehensive patent strategy designed to prevent both direct and indirect infringement.
Patent Landscape in South Korea for the Subject Technology
South Korea has a dynamic pharmaceutical patent environment characterized by:
- Heavy emphasis on innovation: With government support for biotech and pharma R&D, companies actively seek patent protection for novel drugs, formulations, and delivery systems.
- Robust patent examination: KIPO (Korean Intellectual Property Office) rigorously examines pharmaceutical patents, often citing prior art and requiring amendments to claims.
- Filing trends: The number of patent applications related to pharmaceuticals, particularly in biotech and chemically synthesized drugs, continues to rise.
KR20130103826 fits within a broader landscape marked by:
- Patent families: Similar inventions are often filed in multiple jurisdictions, including the US, Europe, and China, to secure global patent protection.
- Patent thickets: There’s significant overlap with patents covering related compounds or formulations, which creates a complex environment requiring strategic patent landscaping.
- Patent expiry and lifecycle management: Analysis of existing patents indicates a typical patent lifespan, necessitating continual innovation or patent filings to maintain market exclusivity.
Compared to international patents:
- KR20130103826’s claims may overlap with existing patents in other jurisdictions, raising considerations regarding freedom-to-operate.
- Its strategic value increases if it leverages unique formulation techniques or chemical modifications not covered elsewhere.
Legal and Commercial Implications
- Infringement risk: Companies developing similar drugs must analyze the scope of KR20130103826’s claims to avoid infringement.
- Patent validity: The patent's validity relies on the novelty and inventive step over prior art, which is constantly evolving.
- Licensing opportunities: The patent holder may license advancements or formulations to other firms, especially if the claims cover broad therapeutic areas.
- Market exclusivity: The patent’s enforceability can provide a competitive moat, especially in South Korea’s lucrative pharmaceutical market.
Remaining Patent Assets and Landscape
- Preceding patents: The patent likely cites prior art, including earlier filings for similar compounds or formulations, which influences its scope and strength.
- Follow-up patents: Subsequent filings may build upon KR20130103826, indicating ongoing innovation efforts.
- Potential oppositions or litigations: Given the high value of pharma patents, legal challenges aimed at revoking or narrowing the claims are common.
Strategic Considerations
For pharmaceutical innovators or competitors, understanding the precise scope of KR20130103826 informs strategic decisions:
- Design-around strategies: Developing alternative compounds or formulations that do not infringe on the claims.
- Patent landscaping: Mapping related patents in Korea and globally assists in identifying opportunities and risks.
- Lifecycle management: Continual innovation and patent filing prolong commercial relevance.
- Regulatory linkage: Patent protection interacts with regulatory approvals, impacting market entry plans.
Key Takeaways
- KR20130103826 offers comprehensive patent protection over a specific pharmaceutical formulation, with claims covering composition, method of manufacture, and therapeutic use.
- Its scope is intentionally broad to prevent competitors from entering similar therapeutic spaces without infringing.
- The patent landscape in South Korea is highly active, with layered patent families and overlapping claims requiring diligent clearance searches.
- Patent validity depends on careful navigation of prior art and continued innovation efforts.
- Strategic use of the patent—through licensing, infringement monitoring, and lifecycle planning—can solidify market position within Korea’s competitive pharmaceutical landscape.
FAQs
1. How does KR20130103826 compare with international patents covering similar drugs?
It likely shares similarities with international patents but is tailored to Korea’s prior art and patent standards, potentially offering unique claims or formulations specific to the Korean market.
2. Can competitors develop similar drugs without infringing KR20130103826?
Yes. By designing around the specific claims—e.g., altering active ingredients, formulations, or methods—competitors can avoid infringement if their innovations are sufficiently distinct.
3. What are the primary factors influencing the patent’s enforceability in Korea?
Factors include the breadth of claims, prior art, patent prosecution history, and whether the patent meets criteria for novelty, inventive step, and industrial applicability.
4. Are there opportunities for patent challenges or oppositions?
Yes. Patents in South Korea can be challenged post-grant through opposition procedures, especially if prior art or validity concerns exist.
5. How does patent landscape analysis support strategic decisions in pharmaceuticals?
It helps identify patent infringement risks, licensing opportunities, technological gaps, and potential areas for innovation, enabling informed R&D and commercialization strategies.
References
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] WIPO Patent Scope Database
[3] Convention on Biological Diversity and Patent Law Regulations
[4] Industry Reports on South Korean Pharmaceutical Patent Trends
